{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:06:57Z","timestamp":1776798417492,"version":"3.51.2"},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<jats:p>&lt;p&gt;&lt;strong&gt;ABSTRACT&lt;\/strong&gt;&lt;br \/&gt;&lt;strong&gt;INTRODUCTION.&lt;\/strong&gt; Mumps is an acute, generalized viral disease whose source of infection is the infected\u00a0person. In 2003, vaccination against mumps became compulsory in Poland, performed according to a twodose\u00a0scheme. The combined MMR vaccine (against measles, mumps and rubella) was introduced as part of the\u00a0Protective Vaccination Program (PVP), which influenced the number of cases in Poland.&lt;br \/&gt;&lt;strong&gt;AIM.&lt;\/strong&gt; The aim of the study was to evaluate the epidemiological indicators of mumps in Poland in 2020 compared\u00a0to previous years.&lt;br \/&gt;&lt;strong&gt;METHODS.&lt;\/strong&gt; The analysis of the epidemiological situation of mumps in Poland in 2020 was based on the\u00a0interpretation of data from the bulletin \u201cInfectious diseases and poisonings in Poland in 2020\u201d and \u201cVaccinations\u00a0in Poland in 2020\u201d.&lt;br \/&gt;&lt;strong&gt;RESULTS.&lt;\/strong&gt; In 2020, 582 cases of mumps were registered in Poland. The total incidence was 1.5 per 100,000\u00a0inhabitants and was lower compared to 2019. The highest incidence was 2.0 per 100,000 inhabitants were\u00a0registered in the \u015awi\u0119tokrzyskie Voivodeship and the lowest \u2013 0.7 in the Dolno\u015bl\u0105skie Voivodeship. The highest\u00a0incidence (24.6\/100,000) was recorded in children aged 5-9 years. The incidence of men (1.8\/100,000) was\u00a0higher than that of women (1.2\/100,000). In 2020, 6 patients were hospitalized in Poland due to mumps, which\u00a0was less than in 2019 (22 patients). The level of vaccination against mumps in children aged 3 was lower by 0.7\u00a0percentage points compared to 2019 and amounted to 91.9% across Poland.&lt;br \/&gt;&lt;strong&gt;CONCLUSIONS.&lt;\/strong&gt; In 2020, there was a decrease in the number of mumps cases compared to the previous year.\u00a0The lower incidence may have been the result of a reduction in mumps virus transmission due to a change in\u00a0population health behavior during the COVID-19 pandemic. Due to the epidemiological threat, the functioning\u00a0of nurseries, kindergartens and schools was also temporarily suspended, which resulted in a reduction in the\u00a0incidence of mumps in younger age groups, which are the main group of patients.&lt;\/p&gt;\n&lt;p&gt;&lt;strong&gt;STRESZCZENIE&lt;\/strong&gt;&lt;br \/&gt;&lt;strong&gt;WST\u0118P.&lt;\/strong&gt; \u015awinka to ostra, uog\u00f3lniona choroba wirusowa, kt\u00f3rej \u017ar\u00f3d\u0142em zaka\u017cenia jest osoba zaka\u017cona.\u00a0W 2003 r. w Polsce szczepienia przeciw \u015bwince sta\u0142y si\u0119 obowi\u0105zkowe, wykonywane wed\u0142ug dwudawkowego\u00a0schematu. W ramach Programu Szczepie\u0144 Ochronnych (PSO) wprowadzono szczepionk\u0119 skojarzon\u0105 MMR\u00a0(przeciw odrze, \u015bwince i r\u00f3\u017cyczce) dla ca\u0142ej populacji dzieci, kt\u00f3rej systematyczne wykonawstwo wp\u0142yn\u0119\u0142o na\u00a0liczb\u0119 zachorowa\u0144 w Polsce.&lt;br \/&gt;&lt;strong&gt;CEL PRACY.&lt;\/strong&gt; Celem pracy by\u0142a ocena wska\u017anik\u00f3w epidemiologicznych dotycz\u0105cych \u015bwinki w Polsce w 2020 r.\u00a0w por\u00f3wnaniu do lat wcze\u015bniejszych.&lt;br \/&gt;&lt;strong&gt;MATERIA\u0141 I METODY.&lt;\/strong&gt; Analiz\u0119 sytuacji epidemiologicznej \u015bwinki w Polsce w roku 2020 przeprowadzono\u00a0na podstawie interpretacji danych z biuletynu ,,Choroby zaka\u017ane i zatrucia w Polsce w 2020 roku\u201d oraz ,,Szczepienia\u00a0ochronne w Polsce w 2020 roku\u201d.&lt;br \/&gt;&lt;strong&gt;WYNIKI.&lt;\/strong&gt; W 2020 r. w Polsce zarejestrowano 582 zachorowa\u0144 na \u015bwink\u0119. Zapadalno\u015b\u0107 og\u00f3\u0142em wynios\u0142a 1,5\u00a0na 100 tys. mieszka\u0144c\u00f3w i by\u0142a ni\u017csza w por\u00f3wnaniu z rokiem 2019. Najwy\u017csz\u0105 zapadalno\u015b\u0107 2,0 na 100 tys.\u00a0mieszka\u0144c\u00f3w zarejestrowano w wojew\u00f3dztwie \u015bwi\u0119tokrzyskim a najni\u017csz\u0105 \u2013 0,7 w woj. dolno\u015bl\u0105skim. Najwy\u017csz\u0105\u00a0zapadalno\u015b\u0107 (24,6\/100 tys.) odnotowano u dzieci w wieku 5-9 lat. Zapadalno\u015b\u0107 m\u0119\u017cczyzn (1,8\/100 tys.) by\u0142a\u00a0wy\u017csza ni\u017c kobiet (1,2\/100 tys.). W 2020 roku w Polsce z powodu \u015bwinki hospitalizowanych by\u0142o 6 chorych,\u00a0by\u0142o to mniej ni\u017c w 2019 r. (22 chorych). Stan zaszczepienia przeciw \u015bwince dzieci w 3 roku \u017cycia by\u0142 ni\u017cszy\u00a0o 0,7 punktu procentowego w por\u00f3wnaniu do 2019 roku i wynosi\u0142 91,9% w skali ca\u0142ej Polski.&lt;br \/&gt;&lt;strong&gt;WNIOSKI.&lt;\/strong&gt; W 2020 r. wyst\u0105pi\u0142 spadek liczby zachorowa\u0144 na \u015bwink\u0119 w por\u00f3wnaniu z poprzednim rokiem.\u00a0Ni\u017csza zapadalno\u015b\u0107 mog\u0142a by\u0107 wynikiem zmniejszenia transmisji wirusa \u015bwinki z powodu zmiany zachowa\u0144\u00a0zdrowotnych populacji w czasie pandemii COVID-19. W zwi\u0105zku z zagro\u017ceniem epidemiologicznym zosta\u0142o\u00a0tak\u017ce czasowo zawieszone funkcjonowanie \u017c\u0142obk\u00f3w, przedszkoli, szk\u00f3\u0142, co spowodowa\u0142o obni\u017cenie zachorowania\u00a0na \u015bwink\u0119 w m\u0142odszych grupach wieku, kt\u00f3re stanowi\u0105 g\u0142\u00f3wn\u0105 grup\u0119 choruj\u0105cych.&lt;\/p&gt;<\/jats:p>","DOI":"10.32394\/pe.76.51","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T09:47:47Z","timestamp":1680688067000},"page":"561-567","source":"Crossref","is-referenced-by-count":2,"title":["Mumps in Poland in 2020"],"prefix":"10.32394","volume":"76","author":[{"given":"J","family":"Bogusz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Paradowska-Stankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2023,4,5]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["\u015awinka w Polsce w 2020 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181098-101659","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181098-101659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:43:53Z","timestamp":1709887433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Mumps-in-Poland-in-2020,181098,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"alternative-id":["181098"],"URL":"https:\/\/doi.org\/10.32394\/pe.76.51","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]}}}